第VII因子 (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "第VII因子" in Japanese language version.

refsWebsite

Global rank Japanese rank

14nih.gov

4^th place

24^th place

10doi.org

2^nd place

6^th place

2ensembl.org

1,626^th place

2,625^th place

2wikipedia.org

low place

2worldcat.org

5^th place

19^th place

1web.archive.org

1^st place

1mcdonaldworley.com

low place

1bmj.com

1,226^th place

1,988^th place

bmj.com

jramc.bmj.com

Hodgetts, T. J.; Kirkman, E.; Mahoney, P. F.; Russell, R.; Thomas, R.; Midwinter, M. (2007-12-01). “UK Defence Medical Services Guidance for the Use of Recombinant Factor VIIA (RFVIIA) in the Deployed Military Setting” (英語). Journal of the Royal Army Medical Corps 153 (4): 307–309. doi:10.1136/jramc-153-04-18. ISSN 0035-8665. PMID 18619169.

doi.org

Wajima, T and Isbister, G K and Duffull, S B (September 2009). “A comprehensive model for the humoral coagulation network in humans”. Clinical Pharmacology and Therapeutics 86 (3): 290–8. doi:10.1038/clpt.2009.87. PMID 19516255.
Marcos-Contreras, Oscar A.; Smith, Shannon M.; Bellinger, Dwight A.; Raymer, Robin A.; Merricks, Elizabeth; Faella, Armida; Pavani, Giulia; Zhou, Shangzhen et al. (2016-02-04). “Sustained correction of FVII deficiency in dogs using AAV-mediated expression of zymogen FVII”. Blood 127 (5): 565–571. doi:10.1182/blood-2015-09-671420. ISSN 1528-0020. PMC 4742547. PMID 26702064.
Roberts HR, Monroe DM, White GC (December 2004). "The use of recombinant factor VIIa in the treatment of bleeding disorders". Blood. 104 (13): 3858–64. doi:10.1182/blood-2004-06-2223. PMID 15328151。
Simpson E; Lin Y; Stanworth S; Birchall J; Doree C; Hyde C (March 2012). "Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia". The Cochrane database of systematic reviews. 3 (3): CD005011. doi:10.1002/14651858.CD005011.pub4. PMID 22419303。
Kenet G, Walden R, Eldad A, Martinowitz U (November 1999). "Treatment of traumatic bleeding with recombinant factor VIIa". Lancet. 354 (9193): 1879. doi:10.1016/S0140-6736(99)05155-7. PMID 10584732。
Hodgetts, T. J.; Kirkman, E.; Mahoney, P. F.; Russell, R.; Thomas, R.; Midwinter, M. (2007-12-01). “UK Defence Medical Services Guidance for the Use of Recombinant Factor VIIA (RFVIIA) in the Deployed Military Setting” (英語). Journal of the Royal Army Medical Corps 153 (4): 307–309. doi:10.1136/jramc-153-04-18. ISSN 0035-8665. PMID 18619169.
Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, Skolnick BE, Steiner T (February 2005). "Recombinant activated factor VII for acute intracerebral hemorrhage". The New England Journal of Medicine. 352 (8): 777–85. doi:10.1056/NEJMoa042991. PMID 15728810。
Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, Skolnick BE, Steiner T (May 2008). "Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage". The New England Journal of Medicine. 358 (20): 2127–37. doi:10.1056/NEJMoa0707534. PMID 18480205。
Carlsson K, Freskgård PO, Persson E, Carlsson U, Svensson M (June 2003). "Probing the interface between factor Xa and tissue factor in the quaternary complex tissue factor-factor VIIa-factor Xa-tissue factor pathway inhibitor". European Journal of Biochemistry. 270 (12): 2576–82. doi:10.1046/j.1432-1033.2003.03625.x. PMID 12787023。
Zhang E, St Charles R, Tulinsky A (February 1999). "Structure of extracellular tissue factor complexed with factor VIIa inhibited with a BPTI mutant". Journal of Molecular Biology. 285 (5): 2089–104. doi:10.1006/jmbi.1998.2452. PMID 9925787。

ensembl.org

May2017.archive.ensembl.org

GRCh38: Ensembl release 89: ENSG00000057593 - Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000031443 - Ensembl, May 2017

mcdonaldworley.com

“Uncontrolled Bleeding and Injury Lawsuit Claims”. 2016年6月16日時点のオリジナルよりアーカイブ。2015年8月26日閲覧。

nih.gov

pubmed.ncbi.nlm.nih.gov

Wajima, T and Isbister, G K and Duffull, S B (September 2009). “A comprehensive model for the humoral coagulation network in humans”. Clinical Pharmacology and Therapeutics 86 (3): 290–8. doi:10.1038/clpt.2009.87. PMID 19516255.
Marcos-Contreras, Oscar A.; Smith, Shannon M.; Bellinger, Dwight A.; Raymer, Robin A.; Merricks, Elizabeth; Faella, Armida; Pavani, Giulia; Zhou, Shangzhen et al. (2016-02-04). “Sustained correction of FVII deficiency in dogs using AAV-mediated expression of zymogen FVII”. Blood 127 (5): 565–571. doi:10.1182/blood-2015-09-671420. ISSN 1528-0020. PMC 4742547. PMID 26702064.
Roberts HR, Monroe DM, White GC (December 2004). "The use of recombinant factor VIIa in the treatment of bleeding disorders". Blood. 104 (13): 3858–64. doi:10.1182/blood-2004-06-2223. PMID 15328151。
Simpson E; Lin Y; Stanworth S; Birchall J; Doree C; Hyde C (March 2012). "Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia". The Cochrane database of systematic reviews. 3 (3): CD005011. doi:10.1002/14651858.CD005011.pub4. PMID 22419303。
Kenet G, Walden R, Eldad A, Martinowitz U (November 1999). "Treatment of traumatic bleeding with recombinant factor VIIa". Lancet. 354 (9193): 1879. doi:10.1016/S0140-6736(99)05155-7. PMID 10584732。
Hodgetts, T. J.; Kirkman, E.; Mahoney, P. F.; Russell, R.; Thomas, R.; Midwinter, M. (2007-12-01). “UK Defence Medical Services Guidance for the Use of Recombinant Factor VIIA (RFVIIA) in the Deployed Military Setting” (英語). Journal of the Royal Army Medical Corps 153 (4): 307–309. doi:10.1136/jramc-153-04-18. ISSN 0035-8665. PMID 18619169.
Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, Skolnick BE, Steiner T (February 2005). "Recombinant activated factor VII for acute intracerebral hemorrhage". The New England Journal of Medicine. 352 (8): 777–85. doi:10.1056/NEJMoa042991. PMID 15728810。
Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, Skolnick BE, Steiner T (May 2008). "Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage". The New England Journal of Medicine. 358 (20): 2127–37. doi:10.1056/NEJMoa0707534. PMID 18480205。
Carlsson K, Freskgård PO, Persson E, Carlsson U, Svensson M (June 2003). "Probing the interface between factor Xa and tissue factor in the quaternary complex tissue factor-factor VIIa-factor Xa-tissue factor pathway inhibitor". European Journal of Biochemistry. 270 (12): 2576–82. doi:10.1046/j.1432-1033.2003.03625.x. PMID 12787023。
Zhang E, St Charles R, Tulinsky A (February 1999). "Structure of extracellular tissue factor complexed with factor VIIa inhibited with a BPTI mutant". Journal of Molecular Biology. 285 (5): 2089–104. doi:10.1006/jmbi.1998.2452. PMID 9925787。

ncbi.nlm.nih.gov

Human PubMed Reference:
Mouse PubMed Reference:
Marcos-Contreras, Oscar A.; Smith, Shannon M.; Bellinger, Dwight A.; Raymer, Robin A.; Merricks, Elizabeth; Faella, Armida; Pavani, Giulia; Zhou, Shangzhen et al. (2016-02-04). “Sustained correction of FVII deficiency in dogs using AAV-mediated expression of zymogen FVII”. Blood 127 (5): 565–571. doi:10.1182/blood-2015-09-671420. ISSN 1528-0020. PMC 4742547. PMID 26702064.

pmc.ncbi.nlm.nih.gov

Marcos-Contreras, Oscar A.; Smith, Shannon M.; Bellinger, Dwight A.; Raymer, Robin A.; Merricks, Elizabeth; Faella, Armida; Pavani, Giulia; Zhou, Shangzhen et al. (2016-02-04). “Sustained correction of FVII deficiency in dogs using AAV-mediated expression of zymogen FVII”. Blood 127 (5): 565–571. doi:10.1182/blood-2015-09-671420. ISSN 1528-0020. PMC 4742547. PMID 26702064.

web.archive.org

“Uncontrolled Bleeding and Injury Lawsuit Claims”. 2016年6月16日時点のオリジナルよりアーカイブ。2015年8月26日閲覧。

wikipedia.org

en.wikipedia.org

GRCh38: Ensembl release 89: ENSG00000057593 - Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000031443 - Ensembl, May 2017

worldcat.org

search.worldcat.org

Marcos-Contreras, Oscar A.; Smith, Shannon M.; Bellinger, Dwight A.; Raymer, Robin A.; Merricks, Elizabeth; Faella, Armida; Pavani, Giulia; Zhou, Shangzhen et al. (2016-02-04). “Sustained correction of FVII deficiency in dogs using AAV-mediated expression of zymogen FVII”. Blood 127 (5): 565–571. doi:10.1182/blood-2015-09-671420. ISSN 1528-0020. PMC 4742547. PMID 26702064.
Hodgetts, T. J.; Kirkman, E.; Mahoney, P. F.; Russell, R.; Thomas, R.; Midwinter, M. (2007-12-01). “UK Defence Medical Services Guidance for the Use of Recombinant Factor VIIA (RFVIIA) in the Deployed Military Setting” (英語). Journal of the Royal Army Medical Corps 153 (4): 307–309. doi:10.1136/jramc-153-04-18. ISSN 0035-8665. PMID 18619169.